Saloni Shirke
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Caribbean Research and Management of Biodiversity Foundation (2021–2022); Larkin Community Hospital (2020–2021); Mercy Hospital (2025); Bristol Hospital (2022); CHI Health Mercy Council Bluffs (2025)
Unknown Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Saloni Shirke's research has focused on a range of medical topics, including the efficacy of anti-inflammatory agents in severe COVID-19 cases and the use of ozonized saline as a prophylactic measure for healthcare workers. Her work also includes case reports on uncommon medical conditions, such as a mycotic pseudoaneurysm following Salmonella gastroenteritis and a convexal subarachnoid hemorrhage in an HIV-positive patient with endocarditis. Shirke has also explored the concept of digital twins across various industries, including healthcare, and has investigated the effectiveness of pneumococcal vaccination in chemotherapy patients. Her scholarship metrics include an h-index of 3, with 9 total publications and 34 citations. She has collaborated with Muhammad G. Arnous and Aswanth Reddy, each on one shared publication.
Metrics
- h-index: 3
- Publications: 9
- Citations: 34
Selected Publications
-
Efficacy of 20-valent pneumococcal vaccination in chemotherapy patients: A first real world report. (2025)
-
Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis (2025)
Collaboration Network
Top Collaborators
- Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis
- Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis
- Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis
- Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis
- Efficacy of 20-valent pneumococcal vaccination in chemotherapy patients: A first real world report.
- Efficacy of 20-valent pneumococcal vaccination in chemotherapy patients: A first real world report.
- Efficacy of 20-valent pneumococcal vaccination in chemotherapy patients: A first real world report.
- Efficacy of 20-valent pneumococcal vaccination in chemotherapy patients: A first real world report.
Similar Researchers
Based on overlapping research topics